Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $12.70 USD
Change Today -0.08 / -0.63%
Volume 1.3M
KERX On Other Exchanges
KERX is not on other exchanges.
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James F. Oliviero CFA

Chief Financial Officer and Treasurer, Keryx Biopharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Mr. James F. Oliviero, CFA has been the Chief Financial Officer of Keryx Biopharmaceuticals Inc. since April 2009. Mr. Oliviero serves as a Treasurer of Keryx Biopharmaceuticals Inc., and served as its Secretary. He is in charge of leading Keryx's compliance with Securities and Exchange Commission rules and regulations and other corporate governance matters. He served as Vice President of Finance at Keryx Biopharmaceuticals Inc. from March 2008 to April 2009. He served ...

Read Full Background

Corporate Headquarters*

750 Lexington Avenue
New York, New York 10022

United States

Phone: 212-531-5965
Fax: 212-531-5961

Board Members Memberships*

There is no Board Members Memberships data available.


Emory University-Goizueta Business School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$405,000

Stock Options*

Restricted Stock Awards$1,644,186
Exercised Options30,000
Exercised Options Value$241,500
Exercisable Options244,771
Exercisable Options Value$830,613
Unexercisable Options82,845
Unexercisable Options Value$840,951
Total Value of Options$1,913,064
Total Number of Options357,616

Total Compensation*

Total Annual Cash Compensation$511,000
Total Short Term Compensation$405,000
Other Long Term Compensation$1,644,186
Total Calculated Compensation$2,262,840
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KERX:US $12.70 USD -0.08


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KERYX BIOPHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at